Journal List > J Korean Soc Spine Surg > v.23(1) > 1076088

Yoon, Lee, Park, Song, Jang, Lee, Lee, and Moon: Effect of Smoking on Osteoporotic Vertebral Fracture in Postmenopausal Women

Abstract

Study Design

A retrospective study.

Objectives

To evaluate the association between smoking and osteoporotic vertebral fractures (OVFs) in postmenopausal women.

Summary of Literature Review

Several studies have examined the relationship of smoking with hip fractures, but few studies have analyzed the relationship of smoking with spine fractures in women thus far.

Materials and Methods

This study considered 1255 postmenopausal women aged 50 years and older (enrollment from April 2008 to January 2009) from 62 study sites in a nationwide hospital. The amount of smoking was calculated in pack-years. Further, OVFs were diagnosed using a semi-quantitative method. To analyze the relationship between smoking and OVFs, we used a paired t-test, a χ2-test, and a binary logistic regression analysis.

Results

The past history of smoking was 7.2% in the patient group and 4.3% in the control group (p=0.025). The mean pack-years of smoking was 0.34 in the control group and 0.62 in the patient group (p=130). The mean T-score in the lumbar bone mass density (BMD) was −1.64 in the control group and −2.19 in the patient group (p=0.409). Smoking was a risk factor of vertebral fractures in postmenopausal women (odd's ratio=1.68, 95% confidence interval=1.020–2.759, p=0.042) irrespective of the lumbar BMD and the medical treatment for osteoporosis and obesity.

Conclusions

Smoking is a risk factor for osteoporotic vertebral fractures in postmenopausal women independently without regard to lumbar BMD. Therefore, cessation of smoking is important for the prevention of OVFs in postmenopausal women.

REFERENCES

1. Kim KH, Lee CM, Park SM, et al. Secondhand smoke ex-posure and osteoporosis in never-smoking postmenopausal women: the Fourth Korea National Health and Nutrition Examination Survey. Osteoporos Int. 2013; 24:523–32.
crossref
2. Kanis JA, Johnell O, Oden A, et al. Smoking and fracture risk: a meta-analysis. Osteoporos Int. 2005; 16:155–62.
crossref
3. Law MR, Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: rec-ognition of a major effect. BMJ. 1997; 315:841–6.
crossref
4. Vestergaard P, Mosekilde L. Fracture risk associated with smoking: a meta-analysis. J Intern Med. 2003; 254:572–83.
crossref
5. Ensrud KE, Cauley J, Lipschutz R, et al. Weight change and fractures in older women. Study of Osteoporotic Fractures Research Group. Arch Intern Med. 1997; 157:857–63.
crossref
6. Felson DT, Zhang Y, Hannan MT, et al. Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res. 1993; 8:567–73.
crossref
7. Hemenway D, Azrael DR, Rimm EB, et al. Risk factors for wrist fracture: effect of age, cigarettes, alcohol, body height, relative weight, and handedness on the risk for distal fore-arm fractures in men. Am J Epidemiol. 1994; 140:361–7.
crossref
8. Williams AR, Weiss NS, Ure CL, et al. Effect of weight, smoking, and estrogen use on the risk of hip and fore-arm fractures in postmenopausal women. Obstet Gynecol. 1982; 60:695–9.
9. Brot C, Jorgensen NR, Sorensen OH. The influence of smoking on vitamin D status and calcium metabolism. Eur J Clin Nutr. 1999; 53:920–6.
crossref
10. Jensen J, Christiansen C, Rodbro P. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. N Engl J Med. 1985; 313:973–5.
crossref
11. Baron JA, Comi RJ, Cryns V, et al. The effect of cigarette smoking on adrenal cortical hormones. J Pharmacol Exp Ther. 1995; 272:151–5.
12. Riebel GD, Boden SD, Whitesides TE, et al. The effect of nicotine on incorporation of cancellous bone graft in an animal model. Spine (Phila Pa 1976). 1995; 20:2198–202.
crossref
13. Genant HK, Wu CY, van Kuijk C, et al. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993; 8:1137–48.
crossref
14. Kim KH, Lee K, Ko YJ, et al. Prevalence, awareness, and treatment of osteoporosis among Korean women: The Fourth Korea National Health and Nutrition Examination Survey. Bone. 2012; 50:1039–47.
crossref
15. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006; 17:1726–33.
crossref
16. Tanko LB, Christiansen C. An update on the antiestrogenic effect of smoking: a literature review with implications for researchers and practitioners. Menopause. 2004; 11:104–9.
17. Rothem DE, Rothem L, Soudry M, et al. Nicotine modu-lates bone metabolism-associated gene expression in osteo-blast cells. J Bone Miner Metab. 2009; 27:555–61.
crossref
18. Broulik PD, Rosenkrancova J, Ruzicka P, et al. The effect of chronic nicotine administration on bone mineral content and bone strength in normal and castrated male rats. Horm Metab Res. 2007; 39:20–4.
crossref
19. Kaufman DW, Slone D, Rosenberg L, et al. Cigarette smoking and age at natural menopause. Am J Public Health. 1980; 70:420–2.
crossref
20. Svendsen OL, Hassager C, Skodt V, et al. Impact of soft tissue on in vivo accuracy of bone mineral measurements in the spine, hip, and forearm: a human cadaver study. J Bone Miner Res. 1995; 10:868–73.
crossref
21. Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Intro-duction. Osteoporos Int. 1998; 8(Suppl 4):S7–80.
22. Cornuz J, Feskanich D, Willett WC, et al. Smoking, smoking cessation, and risk of hip fracture in women. Am J Med. 1999; 106:311–4.
crossref
23. Hoidrup S, Prescott E, Sorensen TI, et al. Tobacco smoking and risk of hip fracture in men and women. Int J Epidemiol. 2000; 29:253–9.

Table 1.
Comparison of bone mineral density between control and vertebral fracture group
  Control group(714) Vertebral fracture group(531) p-value
Age 61.29±7.16 65.75±7.65 <0.001
Height (cm) 155.71±5.17 154.65±5.32 0.001
Weight (kg) 58.07±8.00 56.67±8.83 0.008
Body mass index (kg/m2) 23.96±3.15 23.68±3.42 0.173
Smoking (pack year) 0.34±2.63 0.63±3.41 0.130
Lumbar BMD (mg/cm2) 0.90±0.17 0.83±0.19 <0.001
Lumbar BMD (T-score) −1.64±1.35 −2.19±1.43 <0.001
Femur neck BMD (mg/cmm2) 0.74±0.18 0.67±0.20 <0.001
Femur neck BMD (T-score) −1.34±1.12 −1.96±1.25 <0.001
Total femur BMD (mg/cm2) 0.80±0.16 0.74±0.22 <0.001
Total femur BMD (T-score) −1.03±1.19 −1.62±1.24 <0.001

BMD, bone mineral density.

Table 2.
Comparison of binary variables between control and vertebral fracture group
  control group(714) Vertebral fracture group(531) Odds ratio p-value
Osteoporosis (T-score≤-2.5) 217(30.3%) 249(46.3%) 1.985 <0.001
Treatment of osteoporosis 568(79.2%) 341(63.4%) 0.454 <0.001
History of smoking 31(4.3%) 39(7.2%) 1.730 0.025
Obesity (BMI≥25) 236(33.1%) 177(33.3%) 0.999 0.995

BMI, body mass index.

Table 3.
Relative risk of smoking on vertebral fracture by logistic regression analysis controlling osteoporosis and obesity
  Odds ratio 95% CI p-value
Osteoporosis (T-score≤-2.5) 1.74 1.362-2.224 <0.001
Treatment of osteoporosis 0.508 0.392-0.660 <0.001
History of smoking 1.677 1.020-2.759 0.042
Obesity (BMI≥25) 1.181 0.921-1.513 0.190
Table 4.
Comparison of bone mineral density and prevalence of vertebral fracture between non-smoking group and smoking group
  non-smoking group(1203) smoking group(73) p-value
Lumbar BMD (mg/cm2) 0.87±0.19 0.82±0.19 0.006
Lumbar BMD (T-score) −1.87±1.42 −2.43±1.42 0.001
Femur neck BMD (mg/cm2) 0.71±0.19 0.70±0.20 0.789
Femur neck BMD (T-score) −1.60±1.21 −1.92±1.42 0.035
Total femur BMD (mg/cm2) 0.77±0.19 0.72±0.17 0.042
Total femur BMD (T-score) −1.26±1.26 −1.72±1.35 0.003
Prevalence of vertebral fracture 511(42.3%) 40(54.8%) 0.036
TOOLS
Similar articles